The groundbreaking, seven-hour procedure was carried out at Hadassah Ein Kerem Medical Center by an extensive medical team ...

The FDA has granted a breakthrough device designation to the BiVACOR Total Artificial Heart. Made of titanium, the device uses a magnetically levitated rotor to pump blood in adult patients with ...

The U.S. FDA’s decision to grant breakthrough device designation for Bivacor Inc.’s titanium total artificial heart (TAH) ...

The US Food and Drug Administration (FDA) has granted breakthrough device designation to BiVACOR’s titanium Total Artificial ...

The company has so far treated patients who were weeks or months away from a transplant, but the device is theoretically ...

Hadassah doctors performed the country’s first-ever complete artificial heart transplant on a 63-year-old patient, offering ...

BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

BiVACOR, a clinical-stage medical device company developing the world's first titanium Total Artificial Heart (TAH), today announced that its device has received Breakthrough Device Designation from ...

The groundbreaking, seven-hour procedure was carried out at Hadassah Ein Kerem Medical Center by an extensive medical team, ...

Titanium, the main material of this artificial heart ... of the BiVACOR TAH as a temporary solution for patients suffering from severe heart failure while awaiting a transplant. Four more patients are ...

Dr Paul Jansz, the lead heart transplant surgeon for the Australian procedure at St Vincent’s Hospital in Sydney, speaks of his deep admiration for Timms and shared the vital point in the ...

An Australian man in his forties made medical history by becoming the first person in the world to live for over 100 days with a completely artificial titanium heart while awaiting a transplant.